To access this element change to forms mode OFF
Grant Award View - GA268444
Necessary steps to advance a pluripotent stem cell-derived tissue repair...
GA ID:
GA268444
Agency:
Department of Health and Aged Care
Approval Date:
17-Jun-2022
Publish Date:
4-Oct-2022
Category:
Medical Research
Grant Term:
17-Jun-2022 to 31-Dec-2026
Value (AUD):
$2,065,971.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 21/22 1.1 Health Policy Research and Analysis
Grant Program:
MRFF Research Grants
Grant Activity:
Necessary steps to advance a pluripotent stem cell-derived tissue repair therapy to the clinic for stroke
Purpose:
Despite great hope for stem cell therapies for stroke, clinical trials to date have largely failed due to a focus on safety at the expense of evidence of preclinical efficacy. We recently showed that human stem cell grafts could restore limb function in a stroke model. This study will now preform a series of iterative, necessary preclinical optimisation, safety and functionality testing of a stem cell product suitable for a Phase I clinical trial in stroke patients.
GO ID:
GO Title:
MRFF – Stem Cell Therapies Mission – 2021 Stem Cell Therapies Grant Opportunity
Internal Reference ID:
2022/MRF2017495
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Melbourne
Recipient ABN:
84 002 705 224
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA